M. Bodo et al., EFFECTS OF INTERLEUKINS ON CROUZON FIBROBLAST PHENOTYPE IN-VITRO - RELEASE OF CYTOKINES AND IL-6 MESSENGER-RNA EXPRESSION, Cytokine, 8(10), 1996, pp. 772-783
In Crouzon's syndrome, the cranial morphogenic processes are altered d
ue to the early fusion of the facial and basal cranial bones, Evidence
that Crouzon fibroblasts have an altered phenotype which is modulated
by interleukin 1 (IL-1) and interleukin 6 (IL-6) is provided, [H-3]Th
ymidine incorporation and cell count studies showed that Crouzon fibro
blasts have an accelerated proliferation rate, [H-3]Glucosamine incorp
oration studies, followed by chromatography analysis of culture medium
samples, revealed that the various classes of glycosaminoglycans (GAG
) secreted into the medium were differently distributed in Crouzon and
normal fibroblasts, Crouzon fibroblasts secreted less total GAG, part
icularly hyaluronic acid (HA) and heparan sulfate (HS), but a relative
ly greater quantity of chondroitin sulfate, Type I and III collagen we
re raised in Crouzon fibroblast medium whereas the concentration of fi
bronectin was lower than in normal cells, Interleukin treatment induce
d changes in cell growth and neosynthesis of extracellular matrix macr
omolecules. Both IL-1 and IL-6 stimulated proliferation of Crouzon fib
roblasts, whereas only IL-6 increased [H-3]thymidine incorporation in
normal cells, IL-1 provided a drop in HA and a rise in GAG sulfates in
normal fibroblasts, but caused an opposite effect in Crouzon fibrobla
sts, Type I collagen and fibronectin secretions are differently modula
ted by the cytokines in the two populations, Moreover, level of IL-I a
ble to stimulate [H-3]thymidine incorporation into mouse thymocytes, a
nd level of IL-1 receptor antagonist (IL-1ra), as determined by ELISA,
were higher in pathological than in normal fibroblasts. Also evidence
that levels of IL-lcr and IL-6 proteins measured by ELISA and also IL
-6 mRNA expression are enhanced in Crouzon fibroblasts is provided, Th
ese novel data suggested that, in Crouzon's syndrome, the modification
s in the relative concentrations of the extracellular matrix (ECM) com
ponents associated with the abnormal cytokine networks may alter the b
alance of the microenvironment where the morphogenic events take place
. (C) 1996 Academic Press Limited